Vulnerability · Published Feb 1, 2024 · Assigned by 3DS
CVE-2023-6078OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023
High 8.8
In plain English
A high-severity OS command injection in BIOVIA Materials Studio products from Dassault Systèmes. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 1.6% (higher than 77% of all known vulnerabilities).
Severity (CVSS 3.1)8.8High
Exploit odds (30 days)1.6%top 23.5% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Dassault Systèmes | BIOVIA Materials Studio products | BIOVIA 2021 GoldenBIOVIA 2022 GoldenBIOVIA 2023 Golden |
Weakness: CWE-78 · Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H